Quantcast

Latest Aptamer Stories

2014-07-09 16:28:44

BASKING RIDGE, N.J., July 9, 2014 /PRNewswire/ -- Regado Biosciences, Inc., (NASDAQ: RGDO) today announced that, further to their decision to voluntarily pause enrollment in their REGULATE-PCI trial, the United States Food and Drug Administration (FDA) informed the company today that a clinical hold has been placed on all patient enrollment and dosing of either study drug in the ongoing Phase 3 REGULATE-PCI trial. According to the FDA, this action was taken to formalize the...

2014-06-26 16:24:59

BOULDER, Colo., IRVINE, Calif. and LIEGE, Belgium, June 26, 2014 /PRNewswire/ -- BiOptix, in conjunction with Altermune Technologies announced today the presentation of a poster for "Quantitative SPR Screening of Aptamer-Protein Interactions for Pre-Clinical Development" at the Drug Analysis 2014 meeting in Liege, Belgium. The meeting combines the 10(th) International Symposium of Drug Analysis and the 25(th) Annual International Symposium on Pharmaceutical and Biomedical Analysis...

2014-06-23 08:28:39

MILFORD, Mass., June 23, 2014 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel drugs to treat a number of medical conditions, with a primary focus in antivirals, today announced two presentations at the Nucleic Acid Summit 2014 held June 19-20, 2014 in San Diego. "The research presented continues to expand our understanding of small molecule nucleic acid hybrids (SMNH) and the underlying...

2014-06-23 08:27:50

Phase 1 Clinical Data Highlights Factor IXa as an Excellent Target for Anticoagulation Therapy BASKING RIDGE, N.J., June 23, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of actively controllable aptamer therapeutics for the acute care setting, today announced the publication in the Journal of Thrombosis and Thrombolysis of data from a single escalating-dose Phase 1 clinical trial of the REG2...

2014-06-10 08:29:59

- Transaction Forms Fully-Integrated Oncology Discovery and Development Company LAWRENCEVILLE, N.J. and HUNTSVILLE, Ala., June 10, 2014 /PRNewswire/ -- Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase...

2014-06-03 08:27:57

LONDON, June 3, 2014 Reportbuyer.com has added a new market research report:Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to...

2014-05-14 08:30:11

Conference Call and Webcast, May 14, 2014, at 8:30 a.m. EDT BASKING RIDGE, N.J., May 14, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage, Phase 3 clinical development of the Revolixys(TM) Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug system, today announced its first quarter 2014 corporate highlights and financial results. A conference call and webcast to discuss the results...

2014-04-21 23:05:06

Tissue diagnostics market includes instruments, reagents and kits used to determine the stage, prognosis, and treatment course of the disease; http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html. (PRWEB) April 21, 2014 The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer...

2014-04-13 23:00:56

Metabolomics is one of the fastest growing markets in the scientific arena, finding its application in essential fields such as drug discovery, toxicology assessment, nutrigenomics and biomarker discovery. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) April 13, 2014 The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and...

2014-04-02 20:22:41

REGULATE-PCI Opened to "All Comers" PCI Population BASKING RIDGE, N.J., April 2, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company leading the development of actively controllable therapeutics for acute care cardiovascular indications, today announced that after achieving the 1,000-patient enrollment milestone, enrollment in the REGULATE-PCI trial has been extended to non ST-elevated myocardial infarction (N-STEMI) patients to include the...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related